COVID-19 Vaccine Study on Pregnant Moms Shows Antibodies Transfer in 3rd Trimester
A new study shows getting the COVID-19 vaccine earlier in pregnancy leads to a better transfer of antibodies to the baby.
Northwestern medicine researchers looked at nearly 30 pregnant women who got the Pfizer or Moderna vaccine in the third trimester and the umbilical cord blood of their babies after birth.
They found new moms had a robust immune response to the vaccine and women who got the vaccine earlier in the third trimester were more likely to pass on protective antibodies to their newborns.
Research shows breastfeeding moms can also transfer antibodies to their babies